US4861705A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for removing components of biological fluids
Assignee: Yeda Research and Development Co Ltd
•
Filing: 1986-10-22
•
Granted: 1989-08-29
•
Expires: 2006-10-22
Abstract
Abstract There are provided magnetic and non-magnetic agarose and agar polyaldehyde beads with diameters ranging from 40 microns up to 1 cm, and processes for the synthesis of such beads. The polyaldehyde compounds e.g. polyacrolein, polymethacrolein or polyglutaraldehyde, were used as microspheres or as powders. The agarose-polyaldehyde beads are capable of covalently binding in a single step, through their aldehyde groups, compounds containing primary amino groups or thiol groups, such as proteins, antibodies, enzymes and drugs. The beads are useful for various biological applications e.g. affinity chromatography, hemoperfusion, ion exchange resins, cell labeling, diagnostic purposes and cell separation.
Inventors
- 👤 Shlomo Margel
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 01:16
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54313; G01N33/54326; G01N33/5434; B; B01; B01D; B01D15/00; B01J; B01J20/00; B01J20/22; B01J39/00; B01J39/08; B01J39/16; B01J39/18; B01J41/00; B01J41/08; B01J41/10; C; C07; C07K; C07K1/00; C07K1/14; C07K1/16; C07K1/22; C07K14/00; C07K14/415; C07K14/42; C07K14/435; C07K14/575; C07K14/62; C07K14/76; C07K16/00; C07K16/06; C07K16/065; C08; C08L; C08L5/00; C08L5/12; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6427; B01D15/08; B01D15/26; B01D15/38; B01D15/3804; G01N2400/00; G01N2400/10; G01N2400/12; G01N2400/32; G01N2446/00; G01N2446/10; G01N2446/80; G01N2446/86; Y; Y10; Y10S; Y10S435/00; Y10S435/803
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
166 words
A method of removing a component from a biological fluid which comprises (a) contacting the fluid with substantially spherical, agarose-polyaldehyde beads, each of the beads having a diameter between 40 μm and 2 cm and comprising a polymer which binds to the component and which contains aldehyde groups, the polymer being in the form of substantially uniform microspheres and being a polyacrolein-type compound, polyglutaraldehyde or starch dialdehyde, the microspheres being encapsulated within an aqueous homogeneous, porous matrix of agarose or agar gel, the aldehyde groups of the polymer being bound to a compound containing at least one primary amine or thiol group by means of such amine or thiol group, and the compound to which the polymer is bound being capable of binding to the component to be removed from the fluid, so that the polymer binds to the component; and (b) removing the beads containing the polymer to which the component is bond from the fluid, and thereby removing the component from the biological fluid.
Claim 2
Independent Claim
166 words
A method of removing a component from a biological fluid which comprises (a) contacting the fluid with substantially spherical, agarose-polyaldehyde beads, each of the beads having a diameter between 40 μm and 2 cm and comprising a polymer which binds to the component and which contains aldehyde groups, the polymer being in the form of substantially uniform microspheres and being a polyacrolein-type compound, polyglutaraldehyde or starch dialdehyde, the microspheres being encapsulated within an aqueous homogeneous, porous matrix of agarose or agar gel, the aldehyde groups of the polymer being bound to a compound containing at least one primary amine or thiol group by means of such amine or thiol group, and the compound to which the polymer is bound being capable of binding to the component to be removed from the fluid, so that the polymer binds to the component; and (b) removing the beads containing the polymer to which the component is bond from the fluid, and thereby removing the component from the biological fluid.
Claim 3
Dependent Claim
12 words
A hemoperfusion method of claim 1, wherein the biological fluid is blood.
Claim 4
Dependent Claim
24 words
A method of claim 1, further comprising treating the beads removed from the biological fluid so as to recover the component from the beads.
Claim 5
Dependent Claim
11 words
A method of claim 1, wherein the component is an ion.
Claim 6
Dependent Claim
11 words
A method of claim 1, wherein the compound is a protein.
Claim 7
Dependent Claim
11 words
A method of claim 5, wherein the protein is an antibody.
Claim 8
Dependent Claim
10 words
A method of claim 1, wherein the polymer is polyacrolein.
Claim 9
Dependent Claim
15 words
A method of claim 1, wherein the agarose or agar gel is cross-linked to itself.
References Cited (Backward Citations)
US3879262A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-08-28 | 1993-02-27 | 1993-08-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-08-28 | 1997-02-27 | 1997-08-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-08-28 | 2001-02-27 | 2001-08-29 | $7700.00 | Window Closed / Lapsed |